125 related articles for article (PubMed ID: 2298501)
1. Effect of VIP on the glycogen metabolism of human colon adenocarcinoma cells studied by 13C nuclear magnetic resonance spectroscopy.
Galons JP; Fantini J; Vion-Dury J; Cozzone PJ; Canioni P
Int J Cancer; 1990 Jan; 45(1):168-73. PubMed ID: 2298501
[TBL] [Abstract][Full Text] [Related]
2. Insulin controls key steps of carbohydrate metabolism in cultured HT29 colon cancer cells.
Babia T; Denis-Pouxviel C; Murat JC; Gomez-Foix AM; Trocheris V; Guinovart JJ; Bosch F
Biochem J; 1989 Jul; 261(1):175-9. PubMed ID: 2505753
[TBL] [Abstract][Full Text] [Related]
3. Metabolic changes in undifferentiated and differentiated human colon adenocarcinoma cells studied by multinuclear magnetic resonance spectroscopy.
Galons JP; Fantini J; Vion-Dury J; Cozzone PJ; Canioni P
Biochimie; 1989 Aug; 71(8):949-61. PubMed ID: 2553131
[TBL] [Abstract][Full Text] [Related]
4. 13C- and 31P-NMR studies of human colon cancer in-vitro and in-vivo.
Singer S; Okunieff P; Gostin C; Thilly WG; Chen LB; Neuringer LJ
Surg Oncol; 1993; 2(1):7-18. PubMed ID: 8252195
[TBL] [Abstract][Full Text] [Related]
5. Rates of glycolysis and glycogenolysis during ischemia in glucose-insulin-potassium-treated perfused hearts: A 13C, 31P nuclear magnetic resonance study.
Hoekenga DE; Brainard JR; Hutson JY
Circ Res; 1988 Jun; 62(6):1065-74. PubMed ID: 3289783
[TBL] [Abstract][Full Text] [Related]
6. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J
Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304
[TBL] [Abstract][Full Text] [Related]
7. Insulin regulation of glucose metabolism in HT29 colonic adenocarcinoma cells: activation of glycolysis without augmentation of glucose transport.
Franklin CC; Chin PC; Turner JT; Kim HD
Biochim Biophys Acta; 1988 Oct; 972(1):60-8. PubMed ID: 3052595
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide (VIP) control of glycogenolysis in the human colon carcinoma cell line HT-29 in culture.
Rousset M; Laburthe M; Chevalier G; Boissard C; Rosselin G; Zweibaum A
FEBS Lett; 1981 Apr; 126(1):38-40. PubMed ID: 6263686
[No Abstract] [Full Text] [Related]
9. Glycogen metabolism: a 13C-NMR study on the isolated perfused rat heart.
Lavanchy N; Martin J; Rossi A
FEBS Lett; 1984 Dec; 178(1):34-8. PubMed ID: 6500061
[TBL] [Abstract][Full Text] [Related]
10. Growth of a human colonic adenocarcinoma cell line (HT 29) on microcarrier beads: metabolic studies by 31phosphorus nuclear magnetic resonance spectroscopy.
Fantini J; Galons JP; Marvaldi J; Cozzone PJ; Canioni P
Int J Cancer; 1987 Feb; 39(2):255-60. PubMed ID: 3804495
[TBL] [Abstract][Full Text] [Related]
11. 31P nuclear magnetic resonance study of a human colon adenocarcinoma cultured cell line.
Desmoulin F; Galons JP; Canioni P; Marvaldi J; Cozzone PJ
Cancer Res; 1986 Aug; 46(8):3768-74. PubMed ID: 3731055
[TBL] [Abstract][Full Text] [Related]
12. Hormonal control of fructose 2,6-bisphosphate concentration in the HT29 human colon adenocarcinoma cell line. Alpha 2-adrenergic agonists counteract effect of vasoactive intestinal peptide.
Denis C; Paris H; Murat JC
Biochem J; 1986 Nov; 239(3):531-6. PubMed ID: 3030263
[TBL] [Abstract][Full Text] [Related]
13. Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors.
Luis J; Martin JM; el Battari A; Fantini J; Giannellini F; Marvaldi J; Pichon J
Eur J Biochem; 1987 Sep; 167(2):391-6. PubMed ID: 3040409
[TBL] [Abstract][Full Text] [Related]
14. Nuclear magnetic resonance studies of carbohydrate metabolism and substrate cycling in Fasciola hepatica.
Matthews PM; Foxall D; Shen L; Mansour TE
Mol Pharmacol; 1986 Jan; 29(1):65-73. PubMed ID: 3945228
[TBL] [Abstract][Full Text] [Related]
15. Gluconeogenesis in the liver of tumor rats.
Liu KJ; Henderson TO; Kleps RA; Reyes MC; Nyhus LM
J Surg Res; 1990 Aug; 49(2):179-85. PubMed ID: 2381208
[TBL] [Abstract][Full Text] [Related]
16. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
Couvineau A; Rousset M; Laburthe M
Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide stimulates glycolysis in pituitary tumours; 1H-NMR detection of lactate in vivo.
Maxwell RJ; Prysor-Jones RA; Jenkins JS; Griffiths JR
Biochim Biophys Acta; 1988 Jan; 968(1):86-90. PubMed ID: 3337846
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate metabolism in HT29 colon cancer cells cultured in a glucose free medium supplemented with inosine.
Gauthier T; Denis-Pouxviel C; Murat JC
Int J Biochem; 1989; 21(2):191-6. PubMed ID: 2526033
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of low-density lipoprotein in differentiated and undifferentiated HT29 colon cancer cells.
Viallard V; Lacombe C; Trocheris V; Tabacik C; Aliau S
Int J Cancer; 1990 Aug; 46(2):320-5. PubMed ID: 2384278
[TBL] [Abstract][Full Text] [Related]
20. Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study.
Alcarraz-Vizán G; Sánchez-Tena S; Moyer MP; Cascante M
Biochim Biophys Acta; 2014 Jun; 1840(6):1634-9. PubMed ID: 24368265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
